Active Substance: Granisetron 1 mg / ml.
Overview
Welcome to Dwaey, specifically on GRANI-DENK 1mg/ml page.
This medicine contains an important and useful components, as it consists of
Granisetron 1 mg / mlis available in the market in concentration
Granisetron
Subacute intestinal obstruction or ileus. Moderate to severe hepatic impairment. Congenital long QT syndrome or other risk factors for QT prolongation (e.g. electrolyte abnormalities and cumulative high-dose anthracycline therapy). Pregnancy, lactation. Lactation: excretion in milk unknown; use with caution
Nausea and vomiting,Chemotherapy-induced nausea and vomiting,Post-operative nausea and vomiting
Hypersensitivity.
>10% Headache (10-21%) 1-10% Diarrhea (1-9%),Constipation (3-18%),Asthenia (5%),Somnolence (10%),Sedation (10%),Drowsiness (10%) Frequency Not Defined Anxiety,Fatigue,Malaise,Increased LFTs
2
Granisetron is a selective 5-HT3-receptor antagonist with little or no affinity for other serotonin receptors. It blocks serotonin in the chemoreceptor zone.
Phenobarbital may induce metabolism of granisetron.
Information not available